4
Changes in Ownership
Evommune, Inc. Filed Acc 0001551966-25-000007
Director acquired 3,371,001 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Hopfner Robert Lorne · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-07 | Conversion : show line 1 in the form | +3,026 | 3,026 | I |
| 2025-11-07 | Conversion : show line 2 in the form | +1,441,032 | 1,441,032 | I |
| 2025-11-07 | Conversion : show line 3 in the form | +1,632,441 | 1,632,441 | I |
| 2025-11-07 | Conversion : show line 4 in the form | +294,502 | 294,502 | I |
Table II: Derivative
10 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-07 | Conversion : show line 5 in the form Series Seed Preferred Stock | −25,790 | 0 | I |
| 2025-11-07 | Conversion : show line 6 in the form Series Seed Preferred Stock | −7,145,647 | 0 | I |
| 2025-11-07 | Conversion : show line 7 in the form Series Seed Preferred Stock | −3,572,816 | 0 | I |
| 2025-11-07 | Conversion : show line 8 in the form Series A Preferred Stock | −2,582,243 | 0 | I |
| 2025-11-07 | Conversion : show line 9 in the form Series A Preferred Stock | −7,230,283 | 0 | I |
| 2025-11-07 | Conversion : show line 10 in the form Series B Preferred Stock | −1,895,260 | 0 | I |
| 2025-11-07 | Conversion : show line 11 in the form Series B Preferred Stock | −2,104,740 | 0 | I |
| 2025-11-07 | Conversion : show line 12 in the form Series C Preferred Stock | −313,571 | 0 | I |
| 2025-11-07 | Conversion : show line 13 in the form Series C Preferred Stock | −313,571 | 0 | I |
| 2025-11-07 | Conversion : show line 14 in the form Series C Preferred Stock | −2,508,575 | 0 | I |
Loading xslF345X05/form4-11122025_091138.xml…